Sysmex Corporation. (5/31/17). "Press Release: Sysmex Acquires UK Company to Expand into New Business Domains toward Personalized Medicine". |
2017-05-31 |
Oxford Gene Technology Ltd.. (5/31/17). "Press Release: OGT to Be Acquired by Sysmex Corporation". Oxford. |
2017-05-31 |
Arix Bioscience plc. (5/31/17). "Press Release: Arix Bioscience to Present at Jefferies 2017 Global Healthcare Conference in New York". London. |
2017-05-31 |
Horizon Discovery Group plc. (5/26/17). "Press Release: Horizon Discovery Introduces Four BRAF Resistant Melanoma PDX Models". Cambridge, UK. |
2017-05-26 |
Premaitha Health plc. (5/26/17). "Press Release: Premaitha Completes IONA Test Validation on Thermo Fisher’s Ion S5 Instrument". Manchester. |
2017-05-26 |
Recipharm AB. (5/26/17). "Press Release: Recipharm Makes Strategic Appointment in the UK & Ireland". |
2017-05-26 |
Adaptimmune Therapeutics plc. (5/25/17). "Press Release: Adaptimmune Announces Initiation of Study to Evaluate SPEAR T-Cell Therapy Targeting NY-ESO in Combination with Keytruda (pembrolizumab) in Multiple Myeloma". Philadeliphia, PA & Oxford. |
2017-05-25 |
Unit DX. (5/25/17). "Press Release: First Tenants Welcomed to Unit DX. University Start-ups Become First Tenants in the City’s Newest Science Incubator Unit DX". |
2017-05-25 |
Redx Pharma plc. (5/24/17). "Press Release: Liverpool City Council Call in Loan. Suspension of Trading – Appointment of Administrators". |
2017-05-24 |
Isogenica Ltd.. (5/23/17). "Press Release: Isogenica Announces Renewal Of Licence Agreement By Harpoon Therapeutics". Cambridge, UK. |
2017-05-23 |
AstraZeneca plc. (5/22/17). "Press Release: AstraZeneca Enters Agreement with Recordati for Seloken in Europe". |
2017-05-22 |
Horizon Discovery Group plc. (5/22/17). "Press Release: Horizon Discovery Announces New Gene Editing Technology Platform for Research and Therapeutic Applications". Cambridge, UK. |
2017-05-22 |
BioIndustry Assocation (BIA). (5/22/17). "Press Release: BIA Report Shows UK Is on Track to Build the World’s Third Global Biotech Cluster". |
2017-05-22 |
Evonetix Ltd.. (5/22/17). "Press Release: Evonetix Announces the Appointment of Dr Tim Brears as CEO". Cambridge. |
2017-05-22 |
AstraZeneca plc. (5/19/17). "Press Release: Brodalumab Receives Positive CHMP Opinion for the Treatment of Adult Patients with Moderate-to-severe Plaque Psoriasis". |
2017-05-19 |
Sosei Group Corporation. (5/18/17). "Press Release: Sosei Subsidiary Heptares to Receive US$5 Million Milestone Payment from Teva". Tokyo. |
2017-05-18 |
Intrexon Corporation. (5/18/17). "Press Release: Intrexon Appoints Dr. Mark Carnegie-Brown as CEO of Oxitec". Germantown, MD. |
2017-05-18 |
Abcam plc. (5/18/17). "Press Release: Abcam Makes Final Performance-Based AxioMx Milestone Payment". Cambridge. |
2017-05-18 |
Redx Pharma plc. (5/17/17). "Press Release: Interim Results for the Six Months Ended 31 March 2017". |
2017-05-17 |
Adaptimmune Therapeutics plc. (5/16/17). "Press Release: Adaptimmune Announces Initiation of Study to Evaluate SPEAR T-Cell Therapy Targeting MAGE-A4 in Multiple Solid Tumors". Philadeliphia, PA & Oxford. |
2017-05-16 |
Cell Medica Ltd.. (5/16/17). "Press Release: Jefferies 2017 Global Healthcare Conference". |
2017-05-16 |
Premaitha Health plc. (5/12/17). "Press Release: Update Re. Swiss Customer". Manchester. |
2017-05-12 |
Immunocore Ltd.. (5/12/17). "Press Release: Abbas Hussain Joins the Board of Immunocore as Non-executive Director. Ian T. Clark Also Appointed as Special Adviser to the Board". Oxford & Conshohocken, PA. |
2017-05-12 |
Microsaic Systems plc. (5/11/17). "Press Release: Microsaic Enhances Capabilities of Its 4000 MiD Miniaturised Mass Spectrometer for Bioprocessing Applications". |
2017-05-11 |
Scancell Holdings plc. (5/11/17). "Press Release: Placing Raises £5.0 Million, Issue of Equity and PDMR Shareholding [Not for relase in, into or from any jurisdiction where this would constitute a violation of relavant laws or regulations]". |
2017-05-11 |
Macrophage Pharma Ltd.. (5/11/17). "Press Release: Macrophage Pharma Appoints Development Director. Dr Joanne Bedwell-Garner Joins Management Team". |
2017-05-11 |
Adaptimmune Therapeutics plc. (5/10/17). "Press Release: Adaptimmune Announces Initiation of Study to Evaluate SPEAR T-Cell Therapy Targeting AFP in Liver Cancer". Philadeliphia, PA & Oxford. |
2017-05-10 |
Adaptimmune Therapeutics plc. (5/10/17). "Press Release: Adaptimmune Reports First Quarter 2017 Financial Results". Philadeliphia, PA & Oxford. |
2017-05-10 |
Exscientia Ltd.. (5/9/17). "Press Release: Exscientia Announces EUR 250 Million Collaboration for Multiple-product Development and Licence Option Agreement with Sanofi". |
2017-05-09 |
Microbiotica Ltd.. (5/9/17). "Press Release: Microbiotica Appoints John Shields as Non-Executive Director". |
2017-05-09 |
Consilium Strategic Communications Ltd.. (5/8/17). "Press Release: Consilium Strategic Communications Strengthens Senior International Healthcare Team with the Appointment of Philippa Gardner and Suki Virji". London. |
2017-05-08 |
Fluidigm Corporation. (5/4/17). "Press Release: European Mass Cytometry Consortium Brings CyTOF Technology to Leading Universities to Advance Clinical Research". South San Francisco, CA. |
2017-05-04 |
Cambridge Enterprise. (5/3/17). "Press Release: Spin-out Z Factor Announces £7 million Series A Funding to Bring Lung Treatment to the Clinic". |
2017-05-03 |
MiNA Therapeutics Ltd.. (5/3/17). "Press Release: Sosei Pays GBP 35 Million for an Equity Stake and Acquisition Option Agreement in MiNA Therapeutics". Tokyo & London. |
2017-05-03 |
GammaDelta Therapeutics Ltd.. (5/3/17). "Press Release: GammaDelta Therapeutics Expands Management Team Led by Paolo Paoletti as CEO". London. |
2017-05-03 |
Adaptimmune Therapeutics plc. (5/2/17). "Press Release: Adaptimmune to Present at Upcoming Deutsche Bank 42nd Annual Health Care Conference". Philadeliphia, PA & Oxford. |
2017-05-02 |
Metrion Biosciences Ltd.. (5/2/17). "Press Release: Metrion Biosciences Appoints Chief Operating Officer and Head of Business Development". Cambridge. |
2017-05-02 |
Verona Pharma plc. (4/27/17). "Press Release: Verona Pharma Announces Pricing of Global Offering and Approval to List on the NASDAQ Global Market [Not for any jurisdiction where distribution would constitute a violation of relevant laws]". London. |
2017-04-27 |
Congenica Ltd.. (4/27/17). "Press Release: Congenica Completes Series B Financing Round with Investments from China-based BGI, Healthlink and Future Planet". Cambridge. |
2017-04-27 |
Microsaic Systems plc. (4/26/17). "Press Release: Integration with SCPA Chromatography Software". |
2017-04-26 |
Bactevo Ltd.. (4/25/17). "Press Release: Bactevo Unveils »TIME« a Novel, Game-changing Medicines Discovery Platform". Cambridge. |
2017-04-25 |
Metrion Biosciences Ltd.. (4/24/17). "Press Release: Metrion Biosciences and Venomtech Announce Research Collaboration". Cambridge. |
2017-04-24 |
Bicycle Therapeutics Ltd.. (4/20/17). "Press Release: Bicycle Therapeutics Announces a Candidate Preclinical Milestone in Its Ophthalmology Alliance with Thrombogenics". Cambridge, MA & Cambridge. |
2017-04-20 |
OBN (UK) Ltd.. (4/20/17). "Press Release: OBN Appoints New Director to Enhance Board Expertise". Abingdon. |
2017-04-20 |
Redx Pharma plc. (4/20/17). "Press Release: Appointment of Chairman". |
2017-04-20 |
Oxford Cancer Biomarkers Ltd.. (4/19/17). "Press Release: Oxford Cancer Biomarkers Announces Strategic Collaboration with My-BioMed Biotechnology Co. Ltd.". Oxford. |
2017-04-19 |
Cobra Biologics Ltd.. (4/18/17). "Press Release: Cobra Biologics Embarks On £15m (165m SEK) Gene Therapy Manufacturing Operations Expansion". Keele & Matfors & Södertälje. |
2017-04-18 |
Optibrium Ltd.. (4/11/17). "Press Release: Lhasa and Optibrium Enter Research and Product Development Collaboration". Cambridge & Leeds. |
2017-04-11 |
Consilium Strategic Communications Ltd.. (4/10/17). "Press Release: Consilium Strategic Communications and Westwicke Partners Enter into Joint Venture for Healthcare Focused US IR Advisory". London & Baltimore, MD. |
2017-04-10 |
Adaptimmune Therapeutics plc. (4/10/17). "Press Release: Adaptimmune Therapeutics plc Announces Closing of $42 Million Registered Direct Offering". Philadeliphia, PA & Oxford. |
2017-04-10 |
Microsaic Systems plc. (4/7/17). "Press Release: Microsaic Signs Amended Agreement with Global Partner". |
2017-04-07 |
Pirbright Institute, The. (4/7/17). "Press Release: Dr. Bryan Charleston Appointed as Director of The Pirbright Institute". |
2017-04-07 |
MGB Biopharma Ltd.. (4/6/17). "Press Release: MGB Biopharma Closes $1 Million Financing Round to Finance Manufacturing of MGB-BP-3 for Phase II Study in Clostridium difficile-Associated Disease (CDAD)". Glasgow. |
2017-04-06 |
Adaptimmune Therapeutics plc. (4/5/17). "Press Release: Adaptimmune Therapeutics plc Announces Registered Direct Offering of American Depositary Shares". Philadeliphia, PA & Oxford. |
2017-04-05 |
Heptares Therapeutics Ltd.. (4/5/17). "Press Release: Heptares to Receive US$12 Million Milestone Payment from AstraZeneca". London. |
2017-04-05 |
SkinBioTherapeutics plc. (4/5/17). "Press Release: First Day of Dealings. Company to Trade under Ticker Code SBTX [Not for US, AU, CA, JP, ZA, IE, et al.]". Manchester. |
2017-04-05 |
Nightstar Therapeutics plc. (4/4/17). "Press Release: NightstaRx Appoints Healthcare Finance Leader Senthil Sundaram as Chief Financial Officer". Boston, MA. |
2017-04-04 |
Bicycle Therapeutics Ltd.. (4/3/17). "Press Release: Bicycle Therapeutics Announces Presentations at the 2017 American Association for Cancer Research Annual Meeting". Cambridge, MA & Cambridge. |
2017-04-03 |
LGC Ltd.. (4/3/17). "Press Release: LGC Acquires Axolabs and Invests in GMP Manufacturing Capacity for Therapeutic Nucleic Acids". |
2017-04-03 |
AstraZeneca plc. (3/31/17). "Press Release: Tagrisso (osimertinib) Receives US FDA Full Approval". |
2017-03-31 |
Oxford University Innovation. (3/31/17). "Press Release: Biochemical Superglue Bonds with SpyBiotech’s Vision of Next-generation Vaccines". |
2017-03-31 |
Oxford Biomedica plc. (3/30/17). "Press Release: Oxford BioMedica Notes Acceptance by FDA of a Biologics License Application (BLA) Filing for CTL019". Oxford. |
2017-03-30 |
Redx Pharma plc. (3/30/17). "Press Release: Redx Pharma Awarded US$1 Million Grant by CARB-X". |
2017-03-30 |
Linguamatics Ltd.. (3/28/17). "Press Relase: Linguamatics and Dow Jones Partner to Accelerate Pharma Industry Research". Cambridge & Boston, MA. |
2017-03-28 |
Adaptimmune Therapeutics plc. (3/27/17). "Press Release: Adaptimmune Therapeutics plc Announces Closing of Public Offering and Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares". Philadeliphia, PA & Oxford. |
2017-03-27 |
Adaptimmune Therapeutics plc. (3/27/17). "Press Release: Adaptimmune to Participate in Upcoming Jefferies Immuno-Oncology Summit". Philadeliphia, PA & Oxford. |
2017-03-27 |
Cancer Research UK. (3/24/17). "Press Release: New Era in Precision Medicine for Pancreatic Cancer". |
2017-03-24 |
Unit DX. (3/23/17). "Press Release: Our Opening Event. The future looks bright for Science in Bristol". |
2017-03-23 |
Regeneron Pharmaceuticals, Inc.. (3/22/17). "Press Release: U.K. Biobank, Regeneron and GSK Announce Largest Gene Sequencing Initiative on World's Most Detailed Health Database to Improve Drug Discovery and Disease Diagnosis". Tarrytown, NY. |
2017-03-22 |
Adaptimmune Therapeutics plc. (3/22/17). "Press Release: Adaptimmune Therapeutics plc Prices Public Offering of American Depositary Shares". Philadeliphia, PA & Oxford. |
2017-03-22 |
Microsaic Systems plc. (3/21/17). "Press Release: Audited Financial Results for the Year Ended 31 December 2016". |
2017-03-21 |
Adaptimmune Therapeutics plc. (3/21/17). "Press Release: Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares". Philadeliphia, PA & Oxford. |
2017-03-21 |
OptiBiotix Health plc. (3/21/17). "Press Release: Intention to Float SkinBioTherapeutics". |
2017-03-21 |
Thermo Fisher Scientific Inc.. (3/21/17). "Press Release: Thermo Fisher Scientific and the Cell and Gene Therapy Catapult Collaborate to Optimise Advanced Therapy Supply Chain". London. |
2017-03-21 |
Redx Pharma plc. (3/21/17). "Press Release: Final Results for the Year Ended 30 September 2016". |
2017-03-21 |
Pulmocide Ltd.. (3/20/17). "Press Release: Pulmocide Raises $30 Million in Series B Financing. Funding to Progress Novel Wholly-owned Compounds for RSV and Pulmonary Aspergillosis". London. |
2017-03-20 |
Eurofins Scientific UK. (3/17/17). "Press Release: Eurofins to Invest Millions in New UK Facility". |
2017-03-17 |
AstraZeneca plc. (3/17/17). "Press Release: AstraZeneca and Circassia Enter Strategic Collaboration in Respiratory Disease". |
2017-03-17 |
Cell Medica Ltd.. (3/16/17). "Press Release: £60 Million Series C Financing to Advance Multiple Cancer Programmes". London. |
2017-03-16 |
Adaptimmune Therapeutics plc. (3/15/17). "Press Release: Adaptimmune Broadens Executive Team". Philadeliphia, PA & Oxford. |
2017-03-15 |
AstraZeneca plc. (3/14/17). "Press Release: Lynparza Phase III SOLO-2 Data Demonstrate Progression-free Survival Benefit in BRCA-mutated Ovarian Cancer as Maintenance Therapy". |
2017-03-14 |
Adaptimmune Therapeutics plc. (3/13/17). "Press Release: Adaptimmune Reports Fourth Quarter and Full Year 2016 Financial Results". Philadeliphia, PA & Oxford. |
2017-03-13 |
Heptares Therapeutics Ltd.. (3/13/17). "Press Release: Heptares Enters Agreement with Daiichi Sankyo to Discover and Develop Novel, Small Molecules for the Treatment of Pain". London. |
2017-03-13 |
University of Sheffield. (3/7/17). "Press Release: Keapstone Therapeutics Launched in World-first Partnership to Develop New Drugs for Parkinson’s". |
2017-03-07 |
GlaxoSmithKline plc. (3/6/17). "Press Release: GSK’s MUSCA Study Shows Nucala (mepolizumab) Significantly Improves Quality of Life and Lung Function in Severe Asthma Patients with an Eosinophilic Phenotype". London. |
2017-03-06 |
Merck KGaA. (3/2/17). "Press Release: NICE Expands Positive Recommendation for Erbitux as First-line Treatment for RAS Wild-type mCRC". Darmstadt. |
2017-03-02 |
Adaptimmune Therapeutics plc. (3/2/17). "Press Release: Adaptimmune to Present at the Cowen and Company 37th Annual Health Care Conference". Philadeliphia, PA & Oxford. |
2017-03-02 |
PureTech Health plc. (3/2/17). "Press Release: PureTech Health Appoints Bharatt Chowrira, Ph.D., J.D., as President and Chief of Business and Strategy". Boston, MA. |
2017-03-02 |
Bicycle Therapeutics Ltd.. (3/2/17). "Press Release: Bicycle Therapeutics to Present at Cowen and Company 37th Annual Health Care Conference". Cambridge, MA & Cambridge. |
2017-03-02 |
Arquer Diagnostics Ltd.. (3/1/17). "Press Release: Arquer Diagnostics Awarded Funding Under Innovate UK’s Biocatalyst Programme". Sunderland. |
2017-03-01 |
GlaxoSmithKline plc. (3/1/17). "Press Release: GSK Confirms Closure of Agreement to Divest Anaesthesia Portfolio to Aspen". London. |
2017-03-01 |
AstraZeneca plc. (2/28/17). "Press Release: FDA Approves Once-daily Qtern (dapagliflozin and saxagliptin) Tablets for Adults with Type-2 Diabetes". |
2017-02-28 |
Oxford Biomedica plc. (2/28/17). "Press Release: Appointment of New Chief Financial Officer". Oxford. |
2017-02-28 |
Congenica Ltd.. (2/27/17). "Press Release: Congenica Raises £8M ($10M) in Series B Financing Round to Drive International Expansion of Its Genome Analysis Business". Cambridge. |
2017-02-27 |
Premaitha Health plc. (2/27/17). "Press Release: Completion of Yourgene Acquisition, Issue of Shares and Director Appointments". Manchester. |
2017-02-27 |
AstraZeneca plc. (2/24/17). "Press Release: ZS-9 (sodium zirconium cyclosilicate) Receives Positive CHMP Opinion for the Treatment of Hyperkalaemia". |
2017-02-24 |
Napp Pharmaceuticals Ltd.. (2/24/17). "Press Release: Napp Launches Truxima (rituximab), the First Biosimilar Monoclonal Antibody for the Treatment of Cancer, in the UK". Cambridge. |
2017-02-24 |
PureTech Health plc. (2/24/17). "Press Release: PureTech Health to Present at the Cowen and Company 37th Annual Health Care Conference". Boston, MA. |
2017-02-24 |
Storm Therapeutics Ltd.. (2/24/17). "Press Release: Storm Therapeutics Appoints CEO and Chairman". |
2017-02-24 |
GlaxoSmithKline plc. (2/23/17). "Press Release: Positive Results for Relvar Ellipta Lung Function Study in Patients with Well-controlled Asthma". London. |
2017-02-23 |